Niall M.B. Martin

13.9k total citations · 4 hit papers
47 papers, 10.2k citations indexed

About

Niall M.B. Martin is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Niall M.B. Martin has authored 47 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 33 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Niall M.B. Martin's work include PARP inhibition in cancer therapy (24 papers), DNA Repair Mechanisms (20 papers) and Cancer therapeutics and mechanisms (13 papers). Niall M.B. Martin is often cited by papers focused on PARP inhibition in cancer therapy (24 papers), DNA Repair Mechanisms (20 papers) and Cancer therapeutics and mechanisms (13 papers). Niall M.B. Martin collaborates with scholars based in United Kingdom, United States and Netherlands. Niall M.B. Martin's co-authors include Graeme C.M. Smith, Stephen P. Jackson, Ian Hickson, Christopher J. Lord, Andrew Tutt, Alan Ashworth, Nuala McCabe, Charlotte Knights, Hannah Farmer and Damian A. Johnson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Reviews Drug Discovery.

In The Last Decade

Niall M.B. Martin

45 papers receiving 10.1k citations

Hit Papers

Targeting the DNA repair defect in BRCA mutant cells as a... 2004 2026 2011 2018 2005 2004 2008 2017 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
    2005 4.8k citations Hannah Farmer, Nuala McCabe et al. profile →
  2. Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM
    2004 983 citations Ian Hickson, Caroline J. Richardson et al. Cancer Research profile →
  3. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
    2008 762 citations Sven Rottenberg, Janneke E. Jaspers et al. profile →
  4. Deubiquitylating enzymes and drug discovery: emerging opportunities
    2017 657 citations Jeanine A. Harrigan, Xavier Jacq et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niall M.B. Martin United Kingdom 30 7.6k 6.7k 1.5k 1.4k 802 47 10.2k
Graeme C.M. Smith United Kingdom 42 11.7k 1.5× 8.8k 1.3× 1.7k 1.1× 2.4k 1.8× 1.0k 1.3× 70 15.0k
Alan Lau United Kingdom 31 5.1k 0.7× 5.1k 0.8× 1.2k 0.8× 1.0k 0.8× 691 0.9× 61 7.3k
Ian Hickson United Kingdom 16 4.8k 0.6× 4.2k 0.6× 996 0.7× 1.0k 0.7× 571 0.7× 28 6.4k
Huw D. Thomas United Kingdom 28 4.5k 0.6× 4.3k 0.6× 799 0.5× 801 0.6× 568 0.7× 64 6.2k
Charlotte Knights United Kingdom 6 3.8k 0.5× 3.9k 0.6× 914 0.6× 770 0.6× 515 0.6× 13 5.4k
Nuala McCabe United Kingdom 19 5.1k 0.7× 5.0k 0.8× 1.3k 0.8× 1.2k 0.9× 741 0.9× 43 7.2k
Suzanne Kyle United Kingdom 20 4.2k 0.6× 4.2k 0.6× 804 0.5× 622 0.4× 433 0.5× 23 5.6k
Mark Meuth United Kingdom 37 6.7k 0.9× 3.8k 0.6× 1.1k 0.7× 1.5k 1.0× 670 0.8× 71 8.9k
Elena López‐Knowles United Kingdom 24 4.6k 0.6× 4.3k 0.6× 1.3k 0.9× 2.1k 1.5× 1.2k 1.5× 46 7.3k
Niklas Schultz Sweden 22 5.5k 0.7× 4.3k 0.6× 847 0.6× 1.0k 0.7× 562 0.7× 32 6.9k

Countries citing papers authored by Niall M.B. Martin

Since Specialization
Citations

This map shows the geographic impact of Niall M.B. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niall M.B. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niall M.B. Martin more than expected).

Fields of papers citing papers by Niall M.B. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niall M.B. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niall M.B. Martin. The network helps show where Niall M.B. Martin may publish in the future.

Co-authorship network of co-authors of Niall M.B. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Niall M.B. Martin. A scholar is included among the top collaborators of Niall M.B. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niall M.B. Martin. Niall M.B. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ulahannan, Susanna V., Jason T. Henry, Kathleen N. Moore, et al.. (2025). Abstract CT267: First results of ART0380 (an ATR kinase inhibitor) with low dose irinotecan in advanced or metastatic solid tumors. Cancer Research. 85(8_Supplement_2). CT267–CT267.
3.
4.
Gomez-Salazar, Mario, Yiyun Wang, Niall M.B. Martin, et al.. (2023). Aldehyde Dehydrogenase, a Marker of Normal and Malignant Stem Cells, Typifies Mesenchymal Progenitors in Perivascular Niches. Stem Cells Translational Medicine. 12(7). 474–484. 7 indexed citations
5.
Harrigan, Jeanine A., Xavier Jacq, Niall M.B. Martin, & Stephen P. Jackson. (2017). Deubiquitylating enzymes and drug discovery: emerging opportunities. Nature Reviews Drug Discovery. 17(1). 57–78. 657 indexed citations breakdown →
6.
O’Connor, Lenka Oplustil, Stuart L. Rulten, Aaron Cranston, et al.. (2016). The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models. Cancer Research. 76(20). 6084–6094. 60 indexed citations
7.
Jacq, Xavier, Niall M.B. Martin, Lisa M. Smith, et al.. (2015). Abstract 1728: Discovery of highly selective DUB inhibitors with in vivo pre-clinical anti-tumor activity. Cancer Research. 75(15_Supplement). 1728–1728. 1 indexed citations
8.
Pike, Kurt G., Karine Malagu, Marc Hummersone, et al.. (2013). Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014. Bioorganic & Medicinal Chemistry Letters. 23(5). 1212–1216. 166 indexed citations
9.
Munck, Joanne M., Michael A. Batey, Yan Zhao, et al.. (2012). Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K. Molecular Cancer Therapeutics. 11(8). 1789–1798. 99 indexed citations
10.
Jaspers, Janneke E., Ariena Kersbergen, Ute Boon, et al.. (2012). Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors. Cancer Discovery. 3(1). 68–81. 388 indexed citations
11.
Hay, Trevor, James R. Matthews, Alan Lau, et al.. (2009). Poly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53 -Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with Carboplatin. Cancer Research. 69(9). 3850–3855. 94 indexed citations
12.
Menear, Keith, Sylvie Gomez, Karine Malagu, et al.. (2009). Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR. Bioorganic & Medicinal Chemistry Letters. 19(20). 5898–5901. 51 indexed citations
13.
Klevernic, Iva, Niall M.B. Martin, & Philip Cohen. (2009). Regulation of the activity and expression of ERK8 by DNA damage. FEBS Letters. 583(4). 680–684. 31 indexed citations
14.
Menear, Keith, et al.. (2008). Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Bioorganic & Medicinal Chemistry Letters. 18(14). 3942–3945. 34 indexed citations
15.
Cockcroft, Xiaoling, Sylvie Gomez, Frank Kerrigan, et al.. (2005). Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2235–2238. 79 indexed citations
16.
Hay, Trevor, Helen Jenkins, Owen J. Sansom, et al.. (2005). Efficient Deletion of Normal Brca2-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy. Cancer Research. 65(22). 10145–10148. 51 indexed citations
17.
Tutt, Andrew, Christopher J. Lord, Nuala McCabe, et al.. (2005). Exploiting the DNA Repair Defect in BRCA Mutant Cells in the Design of New Therapeutic Strategies for Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 70(0). 139–148. 149 indexed citations
18.
Smith, Graeme C.M., et al.. (2003). Technical Note: A FlashPlate Assay for the Identification of PARP-1 Inhibitors. SLAS DISCOVERY. 8(3). 347–352. 39 indexed citations
19.
Martin, Niall M.B., et al.. (1996). Pharmacologic and Biochemical Profiles of New Venous Antithrombotic β-D-Xyloside Derivatives: Potential Antiathero/thrombotic Drugs. Seminars in Thrombosis and Hemostasis. 22(3). 247–254. 28 indexed citations
20.
Martin, Niall M.B.. (1979). Essay Assignments and Their Grades.. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graeme C.M. Smith Breakdown of academic impact, for papers by Alan Lau Breakdown of academic impact, for papers by Ian Hickson Breakdown of academic impact, for papers by Huw D. Thomas Breakdown of academic impact, for papers by Charlotte Knights Breakdown of academic impact, for papers by Nuala McCabe Breakdown of academic impact, for papers by Suzanne Kyle Breakdown of academic impact, for papers by Mark Meuth Breakdown of academic impact, for papers by Elena López‐Knowles Breakdown of academic impact, for papers by Niklas Schultz
Rankless by CCL
2026